Purchase Order HHSN272201200013P
Award Date 9/23/11
Potential Completion Date 9/30/12
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $8,734 firm fixed-price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has no set-aside designation....
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $4,266.00, was awarded by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for the purchase of various Illumina sequencing systems, reagents, and related services. The contract is a firm fixed-price purchase order with no set-aside designation. Illumina has received...
- The U.S. Department of Health and Human Services National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,753.75 firm fixed-price delivery order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The award is not designated as a set-aside contract. Through this order, Illumina will provide biosequencing materials to support NIAID's biomedical research activities. Illumina has previously received prime federal contracts and subcontracts...
- This is a federal contract award to Illumina, Inc., a manufacturer of genetic analysis and sequencing equipment, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract is for the delivery of Illumina reagents and consumables, with a ceiling value of $13,750. It is a firm fixed price delivery order contract with no set-aside designation. Illumina has previously been awarded other prime federal contracts and...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for laboratory equipment and supplies. The $11,464.33 firm fixed price contract does not have a set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously been awarded prime contracts and subcontracts with various federal agencies, including the NIH, Centers for...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $61,903.00 firm fixed price contract is for the purchase of a Genome Analyzer Standard sequencing system. The contract has no set-aside designation. Illumina has provided a range of sequencing instruments and related products and services to...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,236.05 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of Illumina Sequencing Kits and will be performed in San Diego, California. The award does not have a set-aside designation. Illumina has previously provided...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), was issued to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $24,385.03 firm fixed price purchase order does not have a set-aside designation. The award supports Illumina's provision of goods and services related to genomic sequencing and analysis, potentially for research and...